首页> 外国专利> Identification of ligands that enable endocytosis, using in vivo manipulation of neuronal fibers

Identification of ligands that enable endocytosis, using in vivo manipulation of neuronal fibers

机译:使用神经元纤维的体内操作鉴定能够进行内吞的配体

摘要

In vivo screening is used to identify and isolate ligands that drive endocytosis (internalisation) of molecules into animal cells. These ligands can transport passenger molecules (drug or diagnostic compounds, genetic vectors, etc.) into targeted classes of cells. A population of candidate ligands, such as a phage display or combinatorial library, is placed in a rat leg, in contact with a sciatic nerve bundle, and a ligature is tightened around the same nerve bundle at the hip. After a delay, to enable ligands that bind to endocytotic receptors on the nerve fibers to be internalised and transported within the fibers, fiber segments are harvested from the ligature site in the hip. Ligands that entered the harvested nerve segments can be isolated, sequenced, reproduced, etc. If desired, rats can be transformed to express human endocytotic receptors, to allow selection of ligands that will be transported into targeted human cells.
机译:体内筛选用于鉴定和分离驱使分子向细胞内吞(内化)的配体。这些配体可以将过客分子(药物或诊断化合物,遗传载体等)运输到目标细胞类别中。将一组候选配体(例如噬菌体展示库或组合文库)放置在大鼠腿部,与坐骨神经束接触,并在髋部的同一神经束周围绑紧绑扎带。延迟一段时间后,为了使与神经纤维上的内吞受体结合的配体能够被内化并在纤维内运输,从臀部的结扎部位收集纤维段。进入收获的神经节段的配体可以被分离,测序,繁殖等。如果需要,可以将大鼠转化为表达人的内吞受体,从而选择可以转运到目标人细胞中的配体。

著录项

  • 公开/公告号US2006280724A1

    专利类型

  • 公开/公告日2006-12-14

    原文格式PDF

  • 申请/专利权人 IAN A. FERGUSON;HIROAKI TANI;

    申请/专利号US20030423683

  • 发明设计人 HIROAKI TANI;IAN A. FERGUSON;

    申请日2003-04-26

  • 分类号C40B30/06;C40B50/06;

  • 国家 US

  • 入库时间 2022-08-21 21:05:13

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号